Page 208 - 80 guidelines for the treatment of malaria_opt
P. 208
nd
Guidelines for the treatment of malaria – 2 edition
transfusion 36, 45, 46
tranmission (settings)
high 8, 12, 26, 35, 37, 45, 51, 54, 112, 114, 125, 128
low(-to-moderate) 7, 11, 26, 30, 35, 45, 47, 51, 54, 109, 111, 112, 114, 125, 129
stable/unstable 5, 12, 32
travellers 1, 5, 30–32, 193
treatment
failure(s) 6, 8, 10, 14–18, 21, 33, 55, 101, 122, 123, 128, 131
first-line 16, 18, 24, 26, 30, 32, 52, 131
guidelines 2, 3, 9, 23, 61, 63, 65, 67, 71, 72, 131, 135, 145
policies 1, 8, 115, 131
pre-referral 24, 29, 30, 32, 39, 40, 72, 161
protocol 2, 71
recommendations 1, 8, 33, 63, 72
second-line 18, 19
U
uncomplicated (falciparum/vivax) see malaria
under five years 10, 12
unstable malaria 5
urine 44, 45, 75, 76, 89, 91, 93, 95, 96, 180
V
ventilation 46
vivax malaria see malaria
vomiting 3, 4, 17, 20, 22, 23, 34, 65, 66, 74, 76, 78, 80, 87, 88, 90, 91, 93, 96, 98, 99, 124, 136, 137, 138, 140, 141,
142, 146, 148, 150, 169, 171, 193
Y
young children 1, 5, 9, 11, 20, 22, 28–0, 32, 39, 40, 97, 98
Z
zidovudine 25, 33, 88
194